---
schema_version: "secwatch.filing_event.v1"
accession: "0001688757-24-000071"
form_type: "8-K"
ticker: "ESTA"
cik: "0001688757"
company_name: "ESTABLISHMENT LABS HOLDINGS INC."
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:19:52.864088+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Establishment Labs Q2 revenue $44.1M, loss narrows; FDA PMA inspection completed

## Summary
- Q2 revenue $44.1M vs $48.6M YoY; gross margin improved to 65.6% from 62.3%.
- Operating loss $9.3M vs $13.7M loss YoY; adjusted EBITDA loss $4.3M vs $9.3M.
- Net loss $17.2M; cash $54.6M, up $14.6M from Dec 2023.
- FY2024 revenue guidance reaffirmed $174M-$184M (+5-11% YoY).
- FDA completed PMA preapproval inspection July 26; Motiva Implants US approval expected soon.

## SEC filing metadata
- accession: 0001688757-24-000071
- form_type: 8-K
- ticker: ESTA
- cik: 0001688757
- company_name: ESTABLISHMENT LABS HOLDINGS INC.
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1688757/000168875724000071/0001688757-24-000071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1688757/000168875724000071/esta-20240806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001688757-24-000071
- JSON: https://secwatch.observer/filing/0001688757-24-000071.json
- Plain text: https://secwatch.observer/filing/0001688757-24-000071.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.